Influence of presurgical idiopathic hyperprolactinemia on relapse rate in operable breast cancer

Int J Biol Markers. 1995 Apr-Jun;10(2):117-8. doi: 10.1177/172460089501000210.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Axilla
  • Breast Neoplasms / blood
  • Breast Neoplasms / complications*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Estrogen Antagonists / therapeutic use
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Hyperprolactinemia / complications*
  • Lymphatic Metastasis
  • Menopause
  • Methotrexate / administration & dosage
  • Middle Aged
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Recurrence, Local / physiopathology
  • Pilot Projects
  • Prolactin / blood
  • Receptors, Estrogen / analysis
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Antagonists
  • Receptors, Estrogen
  • Tamoxifen
  • Prolactin
  • Cisplatin
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF protocol